Last updated: 26 June 2018 at 7:48am EST

James Edeerfield Management... Net Worth




The estimated Net Worth of James Edeerfield Management... is at least $13.7 Milion dollars as of 25 June 2018. James Management owns over 114,034 units of Avadel Pharmaceuticals plc stock worth over $12,998,417 and over the last 6 years James sold AVDL stock worth over $683,064.

James Management AVDL stock SEC Form 4 insiders trading

James has made over 1 trades of the Avadel Pharmaceuticals plc stock since 2018, according to the Form 4 filled with the SEC. Most recently James sold 114,034 units of AVDL stock worth $683,064 on 25 June 2018.

The largest trade James's ever made was selling 114,034 units of Avadel Pharmaceuticals plc stock on 25 June 2018 worth over $683,064. On average, James trades about 114,034 units every 0 days since 2018. As of 25 June 2018 James still owns at least 952,265 units of Avadel Pharmaceuticals plc stock.

You can see the complete history of James Management stock trades at the bottom of the page.



What's James Management's mailing address?

James's mailing address filed with the SEC is 780 3rd Ave, New York, NY 10017, USA.

Insiders trading at Avadel Pharmaceuticals plc

Over the last 8 years, insiders at Avadel Pharmaceuticals plc have traded over $7,791,038 worth of Avadel Pharmaceuticals plc stock and bought 775,568 units worth $4,366,224 . The most active insiders traders include Healthcare Master Fund Ltd ..., Kevin Broadfin Capital, Llc... oraz Naseem Amin. On average, Avadel Pharmaceuticals plc executives and independent directors trade stock every 43 days with the average trade being worth of $381,436. The most recent stock trade was executed by Thomas S Mchugh on 16 January 2024, trading 2,000 units of AVDL stock currently worth $29,000.



What does Avadel Pharmaceuticals plc do?

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.



What does Avadel Pharmaceuticals plc's logo look like?

Avadel Pharmaceuticals plc logo

Complete history of James Management stock trades at Avadel Pharmaceuticals plc

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
25 Jun 2018 James Edeerfield Management...
Sprzedaż 114,034 $5.99 $683,064
25 Jun 2018
952,265


Avadel Pharmaceuticals plc executives and stock owners

Avadel Pharmaceuticals plc executives and other stock owners filed with the SEC include: